HUL 3R Sept16 - 2022
HUL 3R Sept16 - 2022
Right Valuation (RV) ü We maintain a Buy rating on Hindustan Unilever Ltd (HUL) with an unchanged PT of Rs. 2,850.
Leadership position in 80% of portfolio, improving growth outlook and a healthy balance sheet
+ Positive = Neutral – Negative with consistent cash flows makes it a best pick in FMCG space. Stock trades at 59.0x/48.9x its
FY2023E/24E EPS.
Driving growth in core categories through premiumisation, market development through new
What has changed in 3R MATRIX launches, cluster-based approach through WIMI strategy and expansion of distribution network
remain key growth drivers. Revenues to clock CAGR of 14% over FY2022-24.
Old New Consistent fall in key input prices (palm oil prices corrected by 50% from highs) and price hikes
will help margins improve from H2FY2023.
RS Balance sheet stays strong on steady fall in working capital days (by 12 days in FY2022) and
consistent improvement in cash flows and higher dividend payout (90% in FY2022).
RQ
Hindustan Unilever (HUL) registered resilient numbers in FY2022 as revenues grew by 11% y-o-y (volumes
RV rose by 3%) and PAT rose by 9% y-o-y despite headwinds such as pandemic-led uncertainties, inflationary
effects on rural demand and a surge in input prices in H2FY22. The management is focusing on achieving
double-digit earnings growth in the medium to long run led by strategies such as developing the product
basket, lead in the channel of future and building differentiated structures and capabilities in the coming
ESG Disclosure Score NEW years. The Indian consumption market’s structural growth story is intact with low per capita consumption
and low penetration in most categories and improving rural demand for branded products that offer
ESG RISK RATING ample opportunities. HUL is focusing on converting opportunities in growth through growing the core
Updated Jul 08, 2022
25.80 premiumisation, market development and a cluster-based approach. Such a move will also be supported
by a healthy balance sheet, consistent improvement in the cash flows that supports core businesses to
Medium Risk drive consistent growth.
Well-defined strategies for each category to drive consistent growth: HUL is the leader in 80% of its
NEGL LOW MED HIGH SEVERE
product portfolio with an excellent product development strategy and strong distribution backing. More
0-10 10-20 20-30 30-40 40+ than 75% of products gained volume and value market share in FY2022. HUL’s 16 brands garner revenues
Source: Morningstar of more than Rs. 1,000 crore, while two brands have revenues of above Rs. 5,000 crore. Key business
categories have well-defined growth strategies - Beauty & Personal care (BPC) focusing on building
differentiated and purposeful products under core brands and playing on naturals, home care (HC)
Company details focusing on automation of laundry and large opportunities in surfaces provided by pandemic and food &
beverages (F&B) focusing on building a nutrition portfolio to reduce India’s protein deficiency and scale
Market cap: Rs. 5,93,977 cr up in the North & West. It aided key businesses categories to perform well in the tough environment.
52-week high/low: Rs. 2,859 / 1,902 Aiming for double-digit earnings growth: Despite tough demand scenario and inflationary headwinds,
HUL’s PAT grew at CAGR of 13% over FY2020-22 (with revenues growing by ~15%, OPM standing at
NSE volume: 24%). The company has maintained its thrust on achieving double-digit earnings growth by achieving
18.6 lakh sustained volume growth in the core categories of home care and personal care, scaling up the foods &
(No of shares) refreshment business and a gradual improvement in OPM. We expect HUL’s revenues and PAT to clock a
CAGR of 14.5% & 17% over FY2021-24 with expected improvement in the volume growth (from H2FY2023)
BSE code: 500696 led by recovery in consumer demand and consistent market share gains in the key portfolio.
NSE code: HINDUNILVR Raw material pressure under control; OPM to be at 25% in FY2024: Prices of some key inputs such as
palm oil and crude oil derivatives (such LAB and packaging material) corrected from its high in past two-
Free float: three months. Palm oil prices are down by 50% from its high in April 2022, LAB prices are down by ~6-8%,
89.5 cr while reduction in the packaging cost is due to fall in the crude oil prices. Raw material inflation stood at
(No of shares)
20% in Q1FY2023. With a recent correction in the key input prices, the raw material inflation is expected
to cool off from H2FY2023. This will help OPM improve in H2FY2023. We expect OPM to stand at 25%
Shareholding (%) in FY2024 with expected decline in the key input prices and efficiencies through cost-saving initiatives.
Our Call
Promoters 61.9
Valuation – Maintain Buy with an unchanged price target of Rs. 2,850: With a strong portfolio of brands,
FII 13.9 a formidable team with great focus supported by R&D and agile distribution and supply chain, HUL’s
management is focusing on enhancing the shareholder’s value eventually. Recent correction in the key
DII 12.2 input prices augurs well for margins and will gradually boost volume growth in the absence of major price
hikes in the quarters ahead. The stock is currently trading at 59.0x and 48.9x its FY2023E/24E earnings.
Others 12.03 Leading position in some high-penetrated categories, thrust on innovation and market development to
remain competitive and drive consistent earnings growth makes it good pick from long-term perspective. We
Price chart maintain a Buy recommendation on the stock with an unchanged price target of Rs. 2,850.
3100 Key Risks
Sustained slowdown in the rural demand or persistent volatility in key input prices from the current levels
2700 would act as a key risk to our earnings in the near term.
2300
Valuation (standalone) Rs cr
1900
Particulars FY21 FY22 FY23E FY24E
1500 Revenue 46,546 51,693 59,911 67,642
Sep-21
Sep-22
May-22
Jan-22
Win with brands as a force for good, powered by purpose and innovation
Improve the health of the Improve people’s health, Contribute to a fairer, more Win with differentiated science
planet confidence, and wellbeing socially inclusive world and technology
Developing portfolio
Powering the core: HUL is growing its core business by investing in purposeful brands and delivering
superior products. The company is bringing to life its product philosophy of Designing for India and
Winning in Many Indias (WiMI). HUL is also bringing this thought process into Skin Care & Hair Care
with products like Pond’s Light Moisturiser that is specifically designed to perform in hot and humid
weather. HUL continues to strengthen brand equity through consistent, purposeful communication on
its iconic brands. Clinic Plus, Dove and Sunsilk were rated as the Top 3 Hair Care brands in the country
as per ‘Kantar Brand Health Check Report’. Lifebuoy continues to build the habit of handwashing,
through the ‘H for Handwashing’ campaign.
Accelerating market development: HUL’s priority is to drive growth in its five big beauty master-
brands, Dove Pond’s, TRESemmé, Lakmé and Indulekha, which 0span across categories. Through
compelling communication, the company is addressing key category triggers and barriers, as well
as scaling up education-led sampling. The company is also creating new capabilities for driving
‘beauty’ market development through salons, medical marketing, and online marketing, which serves
as a distinct competitive advantage. HUL continues to strengthen its ‘naturals’ strategy by building
specialist brands like Indulekha and Hamam.
Driving premiumisation: HUL continued its strategy of upgrading consumers and premiumising its
portfolio. Premium products outperformed the rest of the portfolio. Through its portfolio which straddles
the price-benefit pyramid, HUL continues to actively engage with consumers in their upgradation
journey. For instance, Surf Excel has been driving upgradation in detergent powders, led by Surf
Excel Easy Wash and Surf Excel Matic. Premiumisation continues to be an important agenda for the
dishwash business and with a strong and scalable consumer contact programme, Vim Liquid continues
to pioneer premiumisation in the country.
FY2022 13 6 3 FY2022 2
FY2021 17 12 2 FY2021 1 1 3
FY2020 11 8 15 FY2020 1
FY2019 4 4 12 FY2019 8 1 1
0 5 10 15 20 25 30 35 0 2 4 6 8 10
Beauty & Personal care Homecare Foods & Refreshment Beauty & Personal care Homecare Foods & Refreshment
progress in its commitment to be gender balanced across its managerial levels within the next few
years. In 2021, the company improved gender balance from 42% to 44% at managerial levels. Another
step in our diversity journey has been the introduction of 250+ women in its extended sales ecosystem
and the addition of 186 women on our shopfloor. In 2021, the company also launched the HUL ProUd
network as an employee resource group for LGBTQI+ employees and allies.
Upskill through lifelong learning: HUL continues to build organisational capabilities with a clear focus
on functional learning to enable its people to upskill and reskill for their roles and help them prepare
for the changing landscape of work. In its latest employee survey, 87% of people in offices and 94% of
people in factories believe that the company provides opportunities for skill development.
Win with brands as a force for good, powered by purpose and innovation
HUL has certain strategies in place towards the Environmental, Social and Governance (ESG)
responsibilities.
17,964
18,000 27.5
%
17,655
27.0
17,500 17,345
26.8 26.5
17,000
16,500 26.0
16,000 25.5
FY2019 FY2020 FY2021 FY2022
Beauty & Personal care revenue PBIT Margin
Homecare (HC)
This segment contributed 31% to the company’s revenue and grew by 19% y-o-y to Rs. 16,578 crore in FY2022
with PBIT margins of 19%. HUL’s dishwash portfolio continued its resilient performance. Vim with its well-
defined purpose of ‘change your outlook, move beyond dishes’ focussed on breaking the societal stereotype
that dishwashing is solely a woman’s responsibility. Based on a clear consumer need, HUL’s home hygiene
brand Domex launched a superior product backed by a breakthrough patented Fresh Guard technology
which fights malodour in toilets for 100 flushes.
Trend in BPC revenue and PBIT margin
17,000 16,578 21.0
16,000 20.0
15,000 19.9
18.8
19.3 19.0
13,959
Rs. crore
14,000 13,642
18.0
%
12,876
13,000
17.0
12,000
16.7
11,000 16.0
10,000 15.0
FY2019 FY2020 FY2021 FY2022
Homecare revenue PBIT Margin
10,000 17.0
%
16.5 16.6
9,000 16.5
8,000 7,450
7,133 16.0
7,000
6,000 15.5
5,000 15.0
FY2019 FY2020 FY2021 FY2022
Foods & Refreshment revenue PBIT Margin
Performance of Subsidiaries
1. Unilever India Exports Limited
Unilever India Exports Limited is a wholly owned subsidiary of the company and is engaged in FMCG
exports business. The focus of the FMCG exports operation is two-fold: to develop overseas markets by
driving distribution of brands, such as Vaseline, Dove, Pears, BRU, Red Label, Lakmé, Horlicks, Boost and
to effectively provide cross-border sourcing of FMCG products to other Unilever companies across the
world. The topline growth of the company was driven by robust growth in Personal Wash, Personal care,
and culinary products portfolio. Brands like Dove, Vaseline, Lakmé, Glow & Lovely, Horlicks, Lifebuoy,
Knorr and Kissan have registered healthy growth in the focused markets.
Lakme Lever Private Limited is a wholly owned subsidiary of the company engaged in Salon’s business
and operates a manufacturing unit at Gandhidham, which carries out job work operations for the company
by manufacturing toilet soaps, bathing bars and detergent bars. The company delivered robust topline
and bottom-line growth led by recovery in the salon business which was impacted by Covid-19 during
FY2021. With focus on safety, quality of operations, expert treatments and prudent cost optimization, the
salon business continues to perform well in the beauty services category. Job work business continues its
strong topline and bottomline growth momentum. It has over 400 owned/managed and franchisee salons.
Innovations like Free Spirits – vibrant colors, Beautysutra facials and manicure/pedicure treatments and
Tresplex hair treatments added excitement to the comprehensive Runway Secrets portfolio. Thematic
campaigns – Good Hair Day, Happy New You and Hair Tech helped gain new clients and sustain existing
ones. Lakmé Salon was awarded several awards notable amongst which are Best Franchisor – Beauty
and Wellness at the Franchise India Summit and Best National Salon Chain at the Salon Congress.
Hindustan Unilever Foundation (HUF) is a not-for-profit company that anchors water management related
community development and sustainability initiatives of Hindustan Unilever Limited. The company
operates the ‘Water for Public Good’ program, with a specific focus on water conservation, building local
community institutions to govern water resources and enhancing farm-based livelihoods through adoption
of judicious water practices. HUF’s programs currently reach over 10,000 villages in 46 Districts in eight
states and two union territories across India in partnership through 15 NGO partners and multiple co-
founders. The Company also supports several knowledge initiatives in water conservation, governance,
and behavior change.
Unilever Nepal Limited (UNL) manufactures, markets and sells detergents, foods and refreshment
products, toilet soaps, personal products, and laundry soaps in Nepal. Transformation programs such as
Distributor Management System and SAP migration are helping in faster decision-making, localized and
swifter innovation delivery and increased speed-to market.
Unilever India Limited is a wholly owned subsidiary of the company that had been incorporated to
leverage the growth opportunities in a fast-changing business environment. Presently, it is setting up its
manufacturing facility at Sumerpur, Uttar Pradesh. It is proposed to manufacture detergent powder at this
facility. This company is on-track to commission its factory and start commercial production in FY2023.
8.0
6.0
the company to post better sales volume ahead of 6.0
4.0 4.0
industry. Rural sales volumes are expected to remain 4.0
2.0
1.0
under pressure in Q2FY2023. However, green shoots 2.0
-
-
are visible - 1) Anticipation of normal monsoon for the Q2FY21 Q3FY21 Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23
fourth consecutive year, 2) better kharif production 3) Volume growth (y-o-y)
higher fertiliser subsidy by the government and 4) a
Source: Company, Sharekhan Research
rise in the agri-commodity prices aiding to generate
higher agri-incomes, which will push the demand in
the quarters ahead. Further with limited price hikes in the core portfolio after recent fall in the key input prices
would help in improving the demand for the products in the key markets.
Decline in the palm oil prices and other key input prices would ease out margin pressure
Prices of some key inputs such as palm oil and crude derivatives (such LAB and packaging material) corrected
from its high in past 2-3 months. Palm oil prices are down by 50% from its high in April,2022, LAB prices down
by ~6-8% and reduction in the packaging cost due to fall in the crude oil prices. Raw material inflation stood
at 20% in Q1FY2023. With recent correction in the key input prices, the raw material inflation is expected to
cool off from H2FY2023. This will help OPM to be much better in H2FY2023. We expect OPM to stand at 25%
in FY2024 with expected decline in the key input prices and efficiencies through cost saving initiatives.
7,000 54.0
52.6
52.1
6,500 51.6
52.0
50.4
6,000 49.5
Palm oil (MYR /Toone)
50.0
5,500
47.4 48.0
%
5,000
46.0
4,500
44.0
4,000
3,500 42.0
3,000 40.0
Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23
Palm oil MYR/TN HUL gross margins
5,000
Palm oil (MYR /Toone)
4,500
4,000
3,500
3,000
Jun-22 Jul-22 Aug-22 Sep-22
Financials in charts
40,000 21.0
%
30,000
19.0
20,000
10,072 12,139
6,886 8,136 8,845 17.0 18.1
10,000 17.8 17.7
17.3 17.0
- 15.0
FY2020 FY2021 FY2022E FY2023E FY2024E FY2020 FY2021 FY2022E FY2023E FY2024E
Revenue PAT OPM NPM
60.0
%
-50
37.1 -63
40.0 31.8 -60 -68
27.1 -70 -70
24.1
-70
-81
20.0 29.3
23.9 -80
18.4 20.5
- -90
FY2020 FY2021 FY2022E FY2023E FY2024E FY2020 FY2021 FY2022E FY2023E FY2024E
RoNW RoCE Working capital days
6,000 60
4,000 40
2,000 20
0 0
FY2018 FY2019 FY2020 FY2021 FY2022 FY2018 FY2019 FY2020 FY2021 FY2022
Cash flow from operations Dividend payout
1,900.0
1,700.0
1,500.0
1,300.0
1,100.0
900.0
700.0
500.0
Mar-15
Mar-16
Nov-17
Jan-21
Apr-17
Aug-21
Dec-18
Dec-19
Oct-16
Sep-15
Feb-22
Sep-22
May-18
Jun-19
Jul-20
Peer Comparison
P/E (x) EV/EBITDA (x) RoCE (%)
Particulars
FY22 FY23E FY24E FY22 FY23E FY24E FY22 FY23E FY24E
Nestle India* 85.3 76.6 72.1 55.0 49.3 47.5 136.4 138.3 127.8
ITC 26.8 22.6 19.6 20.2 16.1 14.2 27.1 32.7 35.4
Godrej Consumer Products 51.1 45.3 38.7 37.4 33.5 29.0 17.3 17.9 19.3
HUL 67.2 59.0 48.9 47.0 41.2 34.4 24.1 27.1 31.8
Source: Company, Sharekhan estimates; *Nestle is a calendar year ending company
About company
HUL is India’s largest FMCG company with a strong presence in the homecare and beauty and personal care
categories. The company is a subsidiary of Unilever Plc (that holds a 67% stake in HUL), the world’s largest
consumer goods company present across 190 countries. With over 40 brands spanning 12 distinct categories
such as personal wash, fabric wash, skin care, hair care, oral care, deodorants, colour cosmetics, beverages,
ice creams, frozen desserts, and water purifiers, HUL is part of the everyday life of millions of consumers
across India. The company’s portfolio includes leading brands such as Lux, Lifebuoy, Surf Excel, Rin, Wheel,
Fair & Lovely, Pond’s, Vaseline, Lakmé, Dove, Clinic Plus, Sunsilk, and Axe.
Investment theme
HUL has a leadership position in highlypenetrated categories such as soaps, detergents, and shampoos in
India. Sustaining product innovation, entering into new categories, premiumisation, and increased distribution
network remain some of the key revenue drivers for the company. The merger of GSK Consumer’s HFD
business will make HUL a formidable play in the HFD segment and will enhance the growth prospects of its
small food business. A strong financial background, robust cash-generation ability, and leadership position
in some key categories give HUL an edge over other companies and, hence, justify the stock’s premium
valuation.
Key Risks
Slowdown in the demand environment: Any slowdown in demand (especially in rural India) would affect
sales of key categories, resulting in moderation of sales volume growth.
Increased input prices: Palm oil and crude derivatives such as linear alkyl benzene are some of the key
raw materials used by HUL. Any significant increase in the prices of some of these raw materials would
affect profitability and earnings growth.
Increased competition in highly penetrated categories: Increased competition in highly penetrated
categories such as soaps and detergents would act as a threat to revenue growth.
Additional Data
Key management personnel
Sanjiv Mehta Chairman and Managing Director
Ritesh Tiwari Executive Director, Finance & IT and Chief Financial Officer
Willem Uijen Executive Director, Supply Chain
Dev Bajpai Executive Director, Legal and Corporate Affairs and Company Secretary
Source: Company Website
Top 10 shareholders
Sr. No. Holder Name Holding (%)
1 Life Insurance Corp of India 4.46
2 Blackrock Inc 1.33
3 Vanguard Group Inc 1.27
4 SBI Funds Management 1.12
5 JP Morgan and Chase 0.58
6 ICICI Prudential Life Insurance Co. 0.58
7 UTI Asset Management Co Ltd 0.40
8 Abrdn PLC 0.37
9 Norges Bank 0.31
10 ICICI Prudential Asset Management Co. 0.29
Source: Bloomberg (Old data)
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a position in the companies mentioned in the article.
Disclaimer: This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity
to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation
and any review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice.
This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official
confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN
has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While
we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies,
their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also,
there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is
prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients
of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments
can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and
risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to
advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach
different conclusions from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any
locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession
this document may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the
views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or
their securities and do not necessarily reflect those of SHAREKHAN. The analyst and SHAREKHAN further certifies that neither he
or his relatives or Sharekhan associates has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or
more in the securities of the company at the end of the month immediately preceding the date of publication of the research report
nor have any material conflict of interest nor has served as officer, director or employee or engaged in market making activity of the
company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the
company and no part of the analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or
views expressed in this document. Sharekhan Limited or its associates or analysts have not received any compensation for investment
banking, merchant banking, brokerage services or any compensation or other benefits from the subject company or from third party
in the past twelve months in connection with the research report.
Either, SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make
market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested
in any of the securities or related securities referred to in this report and they may have used the information set forth herein before
publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company
mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved
in, or related to, computing or compiling the information have any liability for any damages of any kind.
Compliance Officer: Ms. Priya Sonavane; Tel: 022–61150000; email id: [email protected];
For any queries or grievances kindly email [email protected] or contact: [email protected]
Registered Office: Sharekhan Limited, The Ruby, 18th Floor, 29 Senapati Bapat Marg, Dadar (West), Mumbai–400028,
Maharashtra, INDIA, Tel: 022–67502000 / Fax: 022–24327343. Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI (CASH / F&O
/ CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-DP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669;
Research Analyst: INH000006183.
Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com;
Investment in securities market are subject to market risks, read all the related documents carefully before investing.